Statistical Correlation of Liver Function Tests with Coagulation Factor Deficiencies in Laennec’s Cirrhosis^[*]

Summary

Hemorrhage is one of the most serious complications of chronic liver disease. Deficiency of plasma coagulation factors, thrombocytopenia, and increased vascular fragility have been reported in many patients with Laennec’s cirrhosis. Factors V, VII, IX, X and prothrombin were deficient in a majority of the 25 patients included in this study.

Six tests of liver function and seven of plasma coagulation factors were evaluated, using the method of statistical regression analysis. The intercorrelation of tests in each group was evaluated as well as the correlation between liver function tests and plasma coagulation factors. Fibrinogen deficiency was not felt to play a significant role in hemorrhagic diathesis in our cases.

• Literatur

• 1 Warner E. D, Brinkhous K. M, Smith H. P. The Titration of Prothrombin in Certain Plasmas. Arch. Pathol. 18: 587 1934;
• 2 Scanlon G. H, Brinkhous K. M, Warner E. D, Smith H. P, Flynn J. E. Plasma prothrombin and the bleeding tendency with special reference to jaundiced patients and vitamin K therapy. J. Amer. med. Ass. 112: 1898-1901 1939;
• 3 Quick A. J. Coagulation Defect in Sweet Clover Disease and in the Hemorrhagic Chick Disease of Dietary Origin. Amer. J. Physiol. 118: 260-271 1937;
• 4 Schonheyder F. Prothrombin in Chickens. Amer. J. Physiol. 123: 349-358 1938;
• 5 Brett H. R, Snell A. M, Osterberg A. E. Preoperative and Postoperative Administrations of Vitamin K to Patients Having Jaundice. J. Amer. med. Ass. 113: 383-389 1939;
• 6 Quick A. J. The Nature of Bleeding in Jaundice. J. Amer. med. Ass. 110: 1658-1662 1938;
• 7 Fraga F. C. Studies of Blood Coagulation in Liver Pathology. Brazil, Thesis: 138 Faculdade Nacional, Rio de Janeiro; 1955
• 8 Cowling D. C. Coagulation Defects in Liver Disease. J. clin. Path. 09: 347-350 1956;
• 9 Rappaport S. I. Plasma Coagulation Factors in Liver Diseases. Clin. Res. 06: 78 1958;
• 10 Finkbiner R. B, McGovern J. J, Goldstein R, Bunker J. P. Coagulation Defects in Liver Disease and Response to Transfusion during Surgery. Amer. J. Med. 26: 199-213 1959;
• 11 Stefanini M, Petrillo E. The Relative Importance of Plasmatic and Vascular Factors of Hemostasis in the Pathogenesis of the Hemorrhagic Diathesis of Liver Dysfunction. Acta med. scand. 134: 139-145 1949;
• 12 Rees H. M, Ecker E. E. An Improved Method for Counting Blood Platelets. J. Amer. med. Ass. 80: 621-622 1923;
• 13 Lee R. I, White P. D. A Clinical Study of the Coagulation Time of Blood. Amer. J. med. Sci. 145: 495-503 1913;
• 14 Duke W. W. The Relation of Blood Platelets to Hemorrhagic Disease: Description of a Method for Determining the Bleeding Time and Coagulation Time and Report of Three Cases of Hemorrhage Relieved by Transfusion. J. Amer. med. Ass. 55: 1185-1192 1910;
• 15 Hjort P, Rappaport S. I, Owren P. A. A Simple, Specific One-Stage Prothrombin Assay Using Russell’s Viper Venom in Cephalin Suspension. J. Lab. clin. Med. 46: 89-97 1955;
• 16 Lewis M. L, Ware A. G. Estimation of Accelerator Globulin. Proc. Soc. exp. Biol. (N. Y) 84: 640-643 1953;
• 17 Owren P. New Clotting Factors, Fifth Conference on Blood Clotting and Allied Problems. 99-170 Josiah Jr. M. acy. Foundation, New York: 1952
• 18 Lewis J. H, Didisheim P. Differential Diagnosis and Treatment in Hemorrhagic Disease. Arch, intern. Med. 100: 157-168 1957;
• 19 Bachmann F, Duckert F, Koller F. The Stuart-Prower Factor Assay and Its Clinical Significance. Thrombos. Diathes. haemorrh. (Stuttg) 02: 24-38 1958;
• 20 Fowell A. H. Turbidimetric Method of Fibrinogen Assay. Amer. J. clin. Path. 25: 340-342 1955;
• 21 Langdell R. D, Wagner R. H, Brinkhous K. M. Effect of Antihemophilic Factor on the One-Stage Clotting Tests. J. Lab. clin. Med. 41: 637-647 1953;
• 22 Ducci, Watson: Modification of the Method of Malloy and Evelyn, Bilirubin in Serum, Medical and Public Health Methods. 79-81 Lea and Febiger; Philadelphia: 1955
• 23 Weichselbaum T. E. An Accurate and Rapid Method for the Determination of Proteins in Small Amounts of Blood Serum and Plasma. Amer. J. clin. Path. 07: 40-49 1946;
• 24 Durrum E. L. A Microelectrophoretic and Microionophoretic Technique. J. Amer, chem. Soc. 72: 2943-2948 1950;
• 25 Michel H. O. An Electrometric Method for the Determination of Red Blood Cell and Plasma Cholinesterase Activity. J. Lab. clin. Med. 34: 1564-1568 1949;
• 26 Bodansky A. Phosphatase Studies, Determination of Serum Phosphatase, Factors Influencing Accuracy of Determination. J. biol. Chem. 101: 93-104 1933;
• 27 Hodgkinson C. P, Margolis P. R, Luzadre J. H. Etiology and Management of Hypofibrinogenemia of Pregnancy. J. Amer. med. Ass. 154: 557-561 1954;
• 28 MacFadzedan A. J. S, Tsang K. C. On Vascular Fragility in Cryptogenic Splenomegaly with and without Cirrhosis. Brit. J. Haemat. 02: 355-366 1956;
• 29 Graham J. B, Collins Jr. D. L, Godwin I. D, Brinkhous K. M. Antihemophilic Factor: Levels in Canine and Human Plasmas, and Following Liver Injury and Dicumarol. Fed. Proc. (part 1) 10 01: 355 1951;
• 30 Rappaport S. I, Ames S. B, Mikklsen S, Goodman J. R. Plasma Clotting Factors in Chronic Hepatocellular Disease. New Engl. J. Med. 263: 278-282 1960;
• 31 Mindrum G, Glueck H. I. Plasma Prothrombin in Liver Disease: Its Clinical and Prognostic Significance. Ann. intern. Med. 50: 1370-1384 1959;